At what enterprise value was EVERVET PARTNERS acquired in 2022?

You can find the full valuation details of EVERVET PARTNERS on mynth capital. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 13.4x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of EVERVET PARTNERS when it was acquired by FREEMAN SPOGLI?

The exact EV/EBITDA multiple for EVERVET PARTNERS is available on mynth capital. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 13.4x. Join our community for free to access full valuation data and industry trends.

When was EVERVET PARTNERS acquired by FREEMAN SPOGLI?

EVERVET PARTNERS was acquired by FREEMAN SPOGLI in 2022.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the EVERVET PARTNERS acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the EVERVET PARTNERS deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.freemanspogli.com/news/evervet-partners-with-freeman-spogli-co-to-accelerate-growth/

← DATABASE

Home Database Healthcare & PharmaEVERVET PARTNERS

08/2022

EVERVET PARTNERS

Acquired by

FREEMAN SPOGLI

UNITED STATES Health Providers / Outpatient Care / Vet Clinics REV 100m USD - 500m USD

EVERVET PARTNERS acquired by FREEMAN SPOGLI

UNITED STATES Health Providers / Outpatient Care / Vet Clinics REV 100m USD - 500m USD

Context

Freeman Spogli & Co. made a significant investment in EverVet Partners, partnering alongside existing investor Tailwind Capital while EverVet's founders and management retained meaningful equity stakes. The transaction provided growth capital to accelerate EverVet's expansion in the consolidating U.S. veterinary services market. The deal made strategic sense because EverVet's veterinarian-led platform model aligned perfectly with Freeman Spogli's consumer services expertise, while Tailwind's foundational support transitioned into continued partnership. EverVet selected Freeman Spogli for their track record scaling healthcare and consumer brands through organic growth and M&A. The timing capitalized on strong industry tailwinds including pet ownership growth and veterinary workforce shortages, positioning EverVet to capture market share through targeted acquisitions and organic initiatives.

EVERVET PARTNERS, which reported an EBITDA margin of LOGIN in 2022, is valued in this transaction at an EV/EBITDA multiple of LOGIN, a level to compare with the average currently observed in the Healthcare & Pharma sector (13.4x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Healthcare & Pharma market trends

Target

EverVet Partners is a veterinary services platform founded in 2020 and headquartered in Conshohocken, Pennsylvania, United States. The company operates a network of 21 general practice animal hospitals across 10 states, primarily serving the Mid-Atlantic, Midwest, Northeast, and Southeast regions. EverVet provides comprehensive veterinary care including wellness exams, surgeries, diagnostics, dental services, and emergency treatment for pets. Each clinic maintains its local identity while benefiting from the platform's shared resources for technology, recruiting, and operational support. The company partners with independent veterinarians, offering them equity opportunities and clinical autonomy while providing back-office infrastructure. EverVet focuses on being a veterinarian-led organization that prioritizes high-quality animal care and strong employee retention. The platform has grown rapidly in the fragmented U.S. veterinary market by targeting quality practices rather than pursuing volume at any cost. Its model emphasizes cultural alignment with clinic owners and invests heavily in attracting top veterinary talent. Revenue comes from clinic services with a focus on building long-term client relationships through exceptional care.

Ent. Value

Equity Value

Multiples Analysis

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (USD)

Year

Rev

EBITDA

EBIT

2022

2021

Other operations with EVERVET PARTNERS

REFERENCES

Note: Detailed and exact financial metrics (Enterprise Value, Revenue, EBITDA, and precise Multiples) are reserved for Mynth community members. Register for free to unlock full data.

Authors: mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).